ALLO vs ZURA: stock comparison and AI forecast
Allogene Therapeutics, Inc. (ALLO) and Zura Bio Ltd (ZURA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALLO Allogene Therapeutics, Inc.
- Price
- $1.12 -48.4% · 6M
- Market Cap
- $387M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
ZURA Zura Bio Ltd
- Price
- $3.94 -25.9% · 6M
- Market Cap
- $378M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ALLO and ZURA have similar market capitalizations ($387M and $378M).
- Over the last six months ZURA returned -25.9% and ALLO -48.4%.
- ALLO carries 0.26 times debt per unit of equity, against 0.10 times for ZURA.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALLO | ZURA |
|---|---|---|
| Market Cap | $387M | $378M |
| P/B Ratio | 0.89x | 2.13x |
| EPS | $-0.77 | $-1.05 |
| Book Value/Share | $1.26 | $1.85 |
| FCF/Share | $-0.30 | $-0.23 |
Profitability & Margins
| Metric | ALLO | ZURA |
|---|---|---|
| ROE | -37.9% | -52.6% |
| ROA | -30.1% | -48.0% |
| ROIC | -34.8% | -57.4% |
| Operating Margin | -3886.1% | – |
| Net Margin | -3566.7% | – |
| EBT Margin | -3489.0% | – |
| Tax Rate | – | 20.4% |
Financial Health
| Metric | ALLO | ZURA |
|---|---|---|
| Current Ratio | 10.72x | 11.29x |
| D/E Ratio | 0.26x | 0.10x |
| Financial Leverage | 1.26x | 1.10x |
| Interest Coverage | -6.6x | – |
| Working Capital | $308M | $175M |
Cash Flow
| Metric | ALLO | ZURA |
|---|---|---|
| Operating Cash Flow | -$102M | -$22M |
| Free Cash Flow | -$103M | -$22M |
| Capital Spending | -$400K | -$20K |
Income Statement
| Metric | ALLO | ZURA |
|---|---|---|
| Operating Income | -$180M | -$102M |
| Net Income | -$165M | -$94M |
| R&D Expense | $123M | $66M |
Dividend & Shareholder Information
| Metric | ALLO | ZURA |
|---|---|---|
| Shares Outstanding | 345M | 96M |
ALLO vs ZURA: stock comparison and AI forecast
Which is bigger, ALLO or ZURA?
ALLO and ZURA have similar market capitalizations ($387M and $378M).
Which stock performed better over the last six months, ALLO or ZURA?
Over the last six months ZURA returned -25.9% and ALLO -48.4%.
Which one does Intratio's AI model rank higher, ALLO or ZURA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.